Terbinafine Tablet
Product Images NDC 76282-209

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 76282-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Terbinafine is a medication available in the form of tablets, USP, equivalent to 250 mg base. The tablets should be dispensed with an attached patient information leaflet provided by the pharmacist. The usual adult usage should be consulted on the package insert for dosage information. The tablets should be stored in a tightly closed container between 20°C to 25°C. The medication should be protected from light. InvaGen Pharmaceuticals, Inc., a subsidiary of Gipla Ltd., manufactured the medication, and Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, made it available in the market.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.